维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Stepensky D"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Pharmacokinetic-pharmacodynamic analysis of the glucose lowering effect of metformin diabetic rats reveals first-pass pharmacodynamic effect显示文摘	Stepensky D Firedman M Tay I	2002	Drug Metab Dispos2002，30，8：	1
2	Preclinical evaluation of pharmacokinetic pharmacodynamic rationale for oral CR metformin fomulation显示文摘	STEPENSKY D FRIEDMAN M SROUR W	2001	J Controlled Release2001，71，：	1
3	Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms 显示文摘	HOFFMANA A STEPENSKY D LAVY E	2004	Int J Pharm2004，277，：	1
4	O-glycosylated versus nonglyeosylated MUCl-dcrived peptides as potential targets for cy- totoxic immunotherapy of carcinoma 显示文摘	Stepensky D Tzehoval E Vadai E	2006	Clin Exp Immunol2006，143，1：	1
5	Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms显示文摘	HOFFMAN A STEPENSKY D LAVY E	2004	Int J Pharm2004，277，：	1
6	O glycosy- lated versus nonglycosylated MUCl-derived peptides as po- tential targets for cytotoxic immunotherapy of carcinoma显示文摘	Stepensky D Tzehoval E Vadai E Eisenbach L	2006	Clin Exp Immunol2006，143，1：	1
7	O-glycosylated versus non-glycosylated MUCl-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma 显示文摘	Stepensky D Tzehoval E Vadai E	2006	Clin Exp Immunol2006，143，1：	1
8	Pharmacokinetic-pharmacodynamic analysis of the glucose lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect显示文摘	Stepensky D Firedman M Tay I	2002	Drug Metabolism and Disposition2002，30，8：	1
9	Quantitative analysis of drug delivery to the brain via nasal route显示文摘	Kozlovskaya L Abou-Kaoud M Stepensky D	2014	J Control Release2014，189，：	1
10	O-glycosylated ver- sus non-glycosylated MUCl-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma 显示文摘	Stepensky D Tzehoval E Vadai E	2006	Clin Exp Immuno12006，143，1：	1
11	O-glycosylated versus non-glycosylated MUCl-derived peptides as potential targets for ey- totoxic immunotherapy of carcinoma 显示文摘	Stepensky D Tzeboval E Vadai E	2006	Clin Exp Immunol2006，143，1：	1
12	O - glycosylated versus non - glycosylated MUC1 - derived peptides as potential targets for cytotoxic immunotherapy of carcinoma 显示文摘	Stepensky D Tzehoval E Vadai E	2006	Clin Exp Immunol2006，143，：	1
13	Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers显示文摘	Klausner E A Lavy E Stepensky D	2003	J Clin Pharmacol2003，43，7：	1
14	Preclinical evaluation of pharmacokinetic-pharmacodynamic rationale for oral CR metform in formulation 显示文摘	Stepensky D Friedman M Srour W	2001	J Controlled Release2001，71，：	1
15	Intracellulartargeting of PLGA nanoparticles encapsulating antigenicpeptide to the endoplasmic reticulum of dendritic cells andits effect on antigen cross-presentation in vitro显示文摘	Sneh-Edri H Likhtenshtein D Stepensky D	2011	MolPharm2011，8，4：	1
16	O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma显示文摘	Stepensky D Tzehoval E Vadai E	2006	Clin Exp Immunol2006，143，：	1
17	Pharmacokinetic-pharma?codynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect显示文摘	Stepensky D Friedman M Raz I	2002	Drug Metab Dispos2002，30，8：	1
18	Furosemide pharmaco-kinetics and pharmacodynamics following gastroretentive dosageform administration to healthy volunteers显示文摘	Klausner EA Lavy E Stepensky D	2003	J Clin Pharmacol2003，43，7：	1
19	Preclinical evaluation of pharmacokinetic-pharmacodynamic rationale for oral CR metformin formulation显示文摘	Stepensky D Friedman M Srour W	2001	J Controlled Release2001，71，：	1
20	Novel gastroretentivedosage forms : Evaluation of gastroretentivity and its effect on ribo-favin absorption in dogs 显示文摘	Klausner EA Lavy E Stepensky D	2002	Pharm Res2002，19，10：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示